Top Markets
#1 Fake World Assets Fake World Assets +11.59%
#2 TENDIES TENDIES +4.80%
#3 GoPlus Security GoPlus Security +4.67%
#4 Everything Everything +3.70%
#5 TronBank TronBank +3.67%
#6 Janction Janction +3.26%
#7 Prom Prom +3.26%
#8 Tutorial Tutorial +3.00%
#9 DUSK Network DUSK Network +2.91%
#10 Humanity Humanity +2.36%
Coin of the day
Fake World Assets Fake World Assets
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Eargo, Inc. Eargo, Inc.

Eargo, Inc.

EAR
Pozycja w akcjach #34757
Eargo, Inc., a medical device firm, strives to improve the quality of life for... Eargo, Inc., a medical device firm, strives to improve the quality of life for individuals experiencing hearing impairment across the United States. The company focuses on developing and distributing hearing aids, utilizing both direct-to-consumer and extensive omni-channel sales approaches. Founded in 2010, the organization initially operated as Aria Innovations, Inc., before officially changing its name to Eargo, Inc. in November 2014. Its primary corporate hub is located in San Jose, California.
Cena akcji
$2.57
Ostatnia synchronizacja: 2024-02-23
Kapitalizacja rynkowa
$4.99M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Eargo, Inc. (EAR)

Kategoria

Healthcare
Historia stopy dywidendy dla Eargo, Inc. (EAR)
Stopa dywidendy (TTM) dla Eargo, Inc. (symbol akcji: EAR) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Eargo, Inc. (EAR) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
2.23%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
1.03%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
3.69%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US